Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.27.4 (
ribonuclease
)
6,621
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the large granule fraction of rat liver, the density distribution of inhibitor-sensitive neutral
ribonuclease
is similar to that for acid hydrolases and its density distribution is similarly modified by
Triton WR-1339
accumulation in lysosomes. Particulate neutral
ribonuclease
is latent; the enzyme is unmasked by very low digitonin concentrations or hypoosmotic shock. These observations demonstrate that the bulk of liver neutral
ribonuclease
is associated with the lysosomal system. In view of the neutral pH optimum of the enzyme and of some particularities of its distribution in fractionation experiments, the possiblilty of an extrahepatic origin of neutral
ribonuclease
has been investigated. After partial pancreatectomy, a significant decrease is observed in both plasma and liver neutral
ribonuclease
. The effect is specific, for it does not occur for other lysosomal enzymes. Also, labelled bovine pancreatic ribonuclease, when injected intravenously, is taken up by the liver. The sedimentable labelled enzyme has a density distribution similar to the distribution of other foreign proteins, horseradish peroxidase or yeast invertase. These results are explained by the uptake of plasmatic neutral
ribonuclease
from pancreatic origin by the liver.
...
PMID:Hepatic nucleases. Extrahepatic origin and association of neutral liver ribonuclease with lysosomes. 0 Dec 73